Amendment No. 6 to Schedule 13D for Vor Biopharma Inc.

Reprogrammed Interchange LLC and Reid Hoffman filed Amendment No. 6 to Schedule 13D, reporting changes in their ownership of Vor Biopharma Inc. common stock. The amendment details transactions from October 8, 2025, through October 9, 2025, where Reprogrammed Interchange LLC sold shares in open market transactions, resulting in a decrease in ownership by more than one percent. The filing also includes a comprehensive list of transactions over the past 60 days, detailing the number of shares sold and the weighted average sale prices. The amendment reaffirms the reporting persons' shared voting and dispositive power over 1,374,775 shares, representing 20.1% of the outstanding common stock. The filing is signed by Frank Huang, Manager of Reprogrammed Interchange LLC, and Reid Hoffman.